Platelet Drug Trial in Coronary Disease Progression

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1979
To determine the effectiveness of the platelet inhibitor drugs dipyridamole and aspirin in reducing the angiographic progression of coronary artery disease over a five-year period and to test the predictive value of the platelet survival half-life in identifying patients with more rapid progression of coronary disease and development of its complications.
Epistemonikos ID: 1b256171bc51211a368a12adb9644d4e0ad52f7d
First added on: May 03, 2024